Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.

Research in Oncology

doi 10.21608/resoncol.2011.427

Full Text

Abstract

Available in

Date

October 1, 2011

Authors

Mervat Mohamed

Samy Al-Gezawy

Hanan Mostafa

Publisher

Egypts Presidential Specialized Council for Education and Scientific Research

Related search

Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac) in Advanced Urothelial Cancer

Japanese Journal of Urology

Urology

1991

English

Sequential Methotrexate and 5-Fluorouracil, Doxorubicin, and Cisplatin for Advanced Urothelial Cancer

Japanese Journal of Urology

Urology

1992

English

Combination Chemotherapy for Advanced Urothelial Cancer With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac)

Japanese Journal of Urology

Urology

1988

English

Docetaxel as Second Line After Failure of Gemcitabine/Cisplatin Regimen in Advanced and/or Metastatic Urinary Bladder Cancer Patients in Egypt

Research in Oncology

2013

English

Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder

Japanese Journal of Urology

Urology

2015

English

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy

2013

English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

English

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

Journal of Clinical Oncology

English

A Randomized Trial Comparing Methotrexate and Vinblastine (MV) With Cisplatin, Methotrexate and Vinblastine (CMV) in Advanced Transitional Cell Carcinoma: Results and a Report on Prognostic Factors in a Medical Research Council Study

British Journal of Cancer

Cancer Research

Oncology

1998

English

Amanote Research

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.

Research in Oncology

Full Text

Abstract

Date

Authors

Publisher

Related search

Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac) in Advanced Urothelial Cancer

Sequential Methotrexate and 5-Fluorouracil, Doxorubicin, and Cisplatin for Advanced Urothelial Cancer

Combination Chemotherapy for Advanced Urothelial Cancer With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac)

Docetaxel as Second Line After Failure of Gemcitabine/Cisplatin Regimen in Advanced and/or Metastatic Urinary Bladder Cancer Patients in Egypt

Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

A Randomized Trial Comparing Methotrexate and Vinblastine (MV) With Cisplatin, Methotrexate and Vinblastine (CMV) in Advanced Transitional Cell Carcinoma: Results and a Report on Prognostic Factors in a Medical Research Council Study